Pharmaceutical Technology

AUGUST 17, 2022

These programmes will include therapies and vaccines in infectious disease and oncology areas. These molecules synthesised newly are packaged densely into custom lipid nanoparticles (LNPs), which Orna has made to act on the body’s crucial tissues. We look forward to working with the talented scientific and technical teams at Orna.”.

RNA 147

RNA Vaccination Vaccine In-Vivo 147

pharmaphorum

MAY 6, 2024

Shah Capital has stepped up its campaign for change at vaccine producer Novavax, lobbying against the re-election of three directors and executive pay packages in a letter to fellow stockholders.

Packaging 106

Packaging Packaging Vaccination Vaccine 106

BioTech 365

JUNE 1, 2021

$15 Billion Vaccine Storage & Packaging Market – Global Size, Share, Outlook, and Opportunity Analysis to 2027 – ResearchAndMarkets.com $15 Billion Vaccine Storage & Packaging Market – Global Size, Share, Outlook, and Opportunity Analysis to 2027 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The … (..)

Packaging 40

Packaging Packaging Vaccination Vaccine 40

BioTech 365

APRIL 15, 2021

Global Vaccine Storage and Packaging Market is Estimated to Account for US$ 15 Bn by End of 2027, Says Coherent Market Insights (CMI) Global Vaccine Storage and Packaging Market is Estimated to Account for US$ 15 Bn by End of 2027, Says … Continue reading →

Packaging 52

Packaging Packaging Marketing Vaccination 52

BioPharma Reporter

JANUARY 28, 2022

Contract development and manufacturing organization (CDMO), Recipharm, says it has inked a deal with a top 10 big pharma company to support vaccine manufacturing from its facility in Kaysersberg, France.

Packaging 52

Packaging Packaging Vaccination Vaccine 52

BioTech 365

NOVEMBER 26, 2020

Global Pharmaceutical Packaging Equipment Market 2020-2027: Unprecedented Global Push to Expedite COVID-19 Vaccine Development to Spur Demand – ResearchAndMarkets.com Global Pharmaceutical Packaging Equipment Market 2020-2027: Unprecedented Global Push to Expedite COVID-19 Vaccine Development to Spur Demand – ResearchAndMarkets.com DUBLIN–(BUSINESS (..)

Packaging 40

Packaging Packaging Vaccination Vaccine 40

pharmaphorum

MARCH 6, 2024

A £650 million investment package by AstraZeneca in the UK has been held up by Chancellor Jeremy Hunt as a “vote of confidence” in the country’s life sciences sector.

Life Science 111

Life Science Packaging Packaging Manufacturing 111

pharmaphorum

JANUARY 27, 2021

A plant in Wales manufacturing the AstraZeneca COVID-19 vaccine was evacuated on the advice of the authorities today after it was sent a suspicious package. Wockhardt UK in Wrexham this morning received a suspicious package. Wockhardt UK in Wrexham this morning received a suspicious package.

Vaccination 98

Vaccination Vaccine Packaging Packaging 98

pharmaphorum

OCTOBER 7, 2021

Moderna has said it plans to invest $500 million in a new facility for manufacturing mRNA vaccines in Africa, and has kicked off a search to find a suitable country and location. of Africans have been fully vaccinated against COVID-19, and just 15 African nations have met the agency’s objective of 10% coverage.

Vaccination 98

Vaccination Vaccine Manufacturing Packaging 98

XTalks

OCTOBER 25, 2023

The US Food and Drug Administration (FDA) has accepted AstraZeneca’s supplemental biologics license application (sBLA) for a self-administered option of its nasal influenza vaccine FluMist Quadrivalent. FluMist has been in the market since 2003 and is the only intranasal spray vaccine option against flu.

Vaccination 59

Vaccination Vaccine Sales Pharmacy 59

Pharma Packaging Solutions

SEPTEMBER 22, 2023

There are a few common types of biologics, including extracted (taken directly from a living system), semi-synthesized (produced with recombinant DNA technology), vaccines, and gene therapies. Covid-19, flu, coronavirus liquid vaccine vial bottle and syringe set in plastic package container preparing for injection on white background.

Recombinant DNA Technology 52

Recombinant DNA Technology Packaging Packaging Pharma Packaging 52

XTalks

NOVEMBER 23, 2021

Canadian pharma and biotech contract development and manufacturing organization (CDMO) Biovectra has announced plans for building one of the first state-of-the-art mRNA vaccine and biomanufacturing facilities in Canada. Additional production would be performed at other facilities for final packaging. million, respectively.

Manufacturing 98

Manufacturing Vaccination Vaccine Drugs 98

Pharmaceutical Technology

JULY 29, 2022

Pfizer (New York, New York) and Moderna’s (Cambridge, Massachusetts) Omicron-specific Covid-19 vaccines are in late-stage development, have demonstrated good efficacy against the variant and will likely be available to the public later this year to provide an additional booster and increase demand for injectable manufacturing.

Manufacturing 130

Manufacturing Vaccination Vaccine Packaging 130

XTalks

MAY 27, 2021

To help boost production of its COVID-19 vaccine, Moderna has enlisted the services of Samsung Biologics , a contract development and manufacturing organization (CDMO) based in South Korea. The vaccine doses are intended for countries outside the US, with manufacturing planned to commence in the third quarter of 2021.

Manufacturing 98

Manufacturing Production Vaccination Vaccine 98

NY Times

MARCH 24, 2021

Officials said they had found no health risks, but the move deals a blow to the Chinese city’s already troubled inoculation campaign.

Packaging 58

Packaging Packaging Vaccination Vaccine 58

BioSpace

JANUARY 26, 2021

Few details were available, but eye witnesses said a robot was investigating a suspicious package found at the plant. Police have sealed off the area, according to the report.

Packaging 127

Packaging Packaging Manufacturing Vaccination 127

BioTech 365

OCTOBER 1, 2020

BOSTON–(BUSINESS WIRE)–Packaging Technology Group, Inc (PTG), a leading provider of thermal packaging solutions for the biopharmaceutical and life sciences sector, responds to the global pandemic with the launch of its off-the-shelf line of pre-qualified shippers, including an earth-friendly alternative.

Packaging 40

Packaging Packaging Life Science Vaccination 40

Pharma Packaging Solutions

JUNE 30, 2023

Vaccines: Vaccines, many of which are grown in tissue cultures, use microorganisms to provide immunity for specific diseases, and are one of the most wide-spread types of biopharma products. As biopharma technology progresses, becoming both more prevalent and available, the need for high-quality biopharma packaging increases.

Recombinant DNA Technology 52

Recombinant DNA Technology Packaging Packaging Gene Therapy 52

BioPharma Reporter

MARCH 9, 2021

Baxter BioPharma Solutions will provide fill/finish sterile manufacturing services and supply packaging for approximately 60-90 million doses of Modernaâs COVID-19 vaccine this year.

Vaccination 52

Vaccination Vaccine Packaging Packaging 52

Pharmaceutical Technology

DECEMBER 12, 2022

Pharmaceutical companies often outsource different parts of the manufacturing process, including the production of small molecule active pharmaceutical ingredients (APIs) and parenteral packaging, to contract manufacturing organizations (CMOs). Iomab-B met the durable complete remission endpoint.

Manufacturing 147

Manufacturing Drugs Packaging Packaging 147

pharmaphorum

NOVEMBER 26, 2020

The UK’s pharma industry trade body has warned that Brexit could derail the government’s efforts to get coronavirus vaccines to the population, but welcomed other measures in this week’s spending review aimed at reviving the economy after the pandemic.

Vaccination 105

Vaccination Vaccine Life Science Regulation 105

Pfizer

APRIL 14, 2023

Albert Bourla On Ensuring Equitable Access to COVID-19 Vaccines kimkevin Fri, 04/14/2023 - 15:38 Albert Bourla On Ensuring Equitable Access to COVID-19 Vaccines Friday, January 22, 2021 - 11:21am Share We have crossed another milestone in the fight against COVID-19.

Vaccination 52

Vaccination Vaccine Development Manufacturing 52

Pfizer

APRIL 26, 2023

But the underlying question is always the same: How will Pfizer and BioNTech ensure a seamless distribution of our vaccine? With the pandemic still raging, our vaccine will be in high demand and, upon authorization or approval, rapidly utilized to help beat back the virus. In the U.S.,

Vaccination 52

Vaccination Vaccine Manufacturing Containment 52

Pharmaceutical Technology

AUGUST 16, 2022

Even giant pharma companies with large internal production capabilities are leaning on outsourcing to meet market demand for huge numbers of injectables, including high-value biologics and Covid-19 vaccines, according to a GlobalData analysis. Outsourcing may also be pursued if it is more favourable in terms of time and/or cost.

Gene Therapy 162

Gene Therapy Packaging Packaging Contract Packaging 162

World of DTC Marketing

SEPTEMBER 23, 2021

SUMMARY: Pfizer will earn over 26 billion dollars from their COVID vaccine, while Moderna and J&J also look to their vaccines for more profit dollars. trillion social spending package. trillion social spending package. Remember when J&J asked for help from Pfizer on their vaccine?

Vaccination 214

Vaccination Vaccine Drugs Packaging 214

Pharmaceutical Technology

NOVEMBER 30, 2022

These contracts involve the manufacturing of biological and small molecule active pharmaceutical ingredients (APIs), parenteral manufacturing and packaging, and other manufacturing-related tasks. Catalent has been engaged in the parenteral manufacturing and packaging of the anti-IL-4/IL-13 antibody. Regulatory decisions come in.

Manufacturing 130

Manufacturing Packaging Packaging Drugs 130

Pharmaceutical Technology

JULY 14, 2022

Pharmaceutical companies regularly outsource different steps of drug manufacturing processes like parenteral manufacturing and packaging, solid dose, and small molecule or biologic active pharmaceutical ingredient (API) production, among others. Covid-19 vaccines stay in the spotlight.

Manufacturing 130

Manufacturing Drugs Vaccination Vaccine 130

The Pharma Data

MAY 3, 2021

The European Medicines Agency (EMA) is evaluating an application submitted by Pfizer and BioNTech for use of their COVID-19 vaccine in children aged 12 to 15 years. . The vaccine has been authorized by the EU for use in people 16 years and up since December 2020. . Pfizer also shared antibody responses from the younger age group.

Vaccination 52

Vaccination Vaccine Antibody RNA 52

BioTech 365

SEPTEMBER 8, 2020

MAINZ, Germany–(BUSINESS WIRE)–In 2019, SCHOTT announced a $1 billion investment in its pharmaceutical packaging business to expand capacity by more than 50 percent. Now, SCHOTT has achieved a milestone, delivering vials to three out of every four COVID-19 vaccine projects … Continue reading →

Vaccination 40

Vaccination Vaccine Packaging Packaging 40

BioTech 365

OCTOBER 2, 2020

SAN DIEGO–(BUSINESS WIRE)–$Cell #ipsc–Allele Biotechnology and Pharmaceuticals, Inc. has been using mRNA as its core technology for creating cGMP-grade iPSC (induced pluripotent stem cells) lines for regenerative medicine and oncology for over a decade. At the onset of the COVID-19 … Continue reading →

Packaging 40

Packaging Packaging Vaccination Vaccine 40

Scienmag

DECEMBER 9, 2020

Is “on-demand” vaccine development the only feasible option to combat unpredictable infections, such as those causing viral pandemics? How can we make patent-free and improved equivalents to existing medicines? What is the key to understanding how the collective memories and legacies of historic empires are created?

Packaging 40

Packaging Packaging Research Vaccination 40

BioPharma Reporter

MAY 27, 2022

The South Korean company moves to include the raw materials behind mRNA vaccines as part of its CDMO package.

Packaging 52

Packaging Packaging Vaccination Vaccine 52

The Pharma Data

JANUARY 16, 2021

16, 2021 — President-elect Joe Biden described an ambitious national vaccination plan on Friday that will deliver coronavirus vaccines to far more people and invoke a wartime law to boost vaccine production. Even if Biden invokes the Korean War-era Defense Production Act, it may take some time to ease vaccine shortages.

Vaccination 52

Vaccination Vaccine Nurses Packaging 52

XTalks

JULY 20, 2022

million state-of-the-art mRNA vaccine and biomanufacturing facility, making it one of the first in the country. The cutting-edge plant will be dedicated to the manufacturing of mRNA vaccines and therapeutics. Related: Biovectra to Build First mRNA Vaccine and Drug Manufacturing Plant in Canada. Learn more! In addition to a $39.8

Vaccination 105

Vaccination Vaccine Manufacturing Life Science 105

The Pharma Data

DECEMBER 16, 2020

Food and Drug Administration (FDA) advisory panel in regard to the COVID-19 vaccine from Moderna. The Vaccines and Related Biological Products Advisory Committee will be determining whether the product should be authorized for emergency use, according to CNBC. The vote itself is not slated to take place until after 3 p.m.

Vaccination 52

Vaccination Vaccine Immune Response FDA Approval 52

XTalks

DECEMBER 1, 2021

The editorial team talked about the emergence of variants amid low vaccine uptake in some parts of the world owing to vaccine inequities and vaccine hesitancy. Omicron’s transmissibility, severity and the effectiveness of the current vaccines against it remain unknown.

Life Science 52

Life Science Packaging Packaging Drugs 52

The Pharma Data

AUGUST 24, 2020

China is set to move ahead with human testing of a potential coronavirus vaccine that has been created using insect cells. It is hoped that using insect cells to grow proteins for the vaccine could speed up large-scale production. These were primarily border officials and health workers. Conor Kavanagh. Source link.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52